| Course | DNP 810 Emerging Areas of Human Health |
|---|---|
| Topic | Topic 8 |
| Paper type | Course synthesis for practice |
| Length | About 2,070 words, 5 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | October 2026 |
Free sample paper for DNP 810 Topic 8
Four Changes, Three Constants and One Item on Hold: What Emerging Areas of Human Health Changes in a Rural Primary Care Visit
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
DNP-810: Emerging Areas of Human Health
Topic 8 Assignment
[Instructor Name]
March 1, 2027
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Four Changes, Three Constants and One Item on Hold: What Emerging Areas of Human Health Changes in a Rural Primary Care Visit
The Setting and the Level of Change
This synthesis asks one question of the course: what should be done differently in a single visit at the rural primary care practice, a composite, where I see patients as a family nurse practitioner. It sees about 9,000 patients a year, has three clinicians, two medical assistants and a part-time nurse care coordinator, and relies on a regional health system for specialty care, imaging and genetic counseling. I have deliberately held the analysis at the level of the individual visit. System changes, such as how the county funds surveillance or where freight routes run, came up repeatedly in the course, and several of them matter more to population health than anything I do in an exam room. They are not mine to schedule, however, and a synthesis that mixes what I can do on Monday with what a legislature might do in a decade produces a list nobody can act on.
Each topic was therefore read with one filter: does it give me something a colleague could put on a task list, assign to a person and check later? Items that passed became changes. Items that were important but produced no visit-level action were sorted as constants, with the reason. One item passed the filter in principle but fails in practice because of how our record handles results, and it is placed on hold with the condition that would release it.
Four Changes, Each Stated as an Action
Table 1
Visit-Level Changes Drawn From the Course
| Change | Source | Action at the visit | Owner |
|---|---|---|---|
| A question added | Topic 4 | At every visit for a child with asthma, the medical assistant asks whether the home is within a few blocks of the interstate or a truck route and records the answer in a structured field. | Medical assistant |
| A referral threshold lowered | Topics 1 and 3 | A positive brief familial risk tool, or any relative with a known pathogenic variant, triggers a genetic counseling referral at that visit without waiting for a second risk factor. | Treating clinician |
| A check performed | Topic 1 | Before clopidogrel is started, the clinician searches the scanned outside results for a CYP2C19 genotype and documents that the search was done. | Prescribing clinician |
| An owner assigned | Topic 6 | Every send-out result expected after the visit is logged with a due date and the name of the person responsible, and the patient's phone number is confirmed before the patient leaves. | Nurse care coordinator |
Table 1 lists the four changes with the topic each came from, the action itself and the person who owns it. The paragraphs that follow give the reasoning for each.
The Question About the Interstate
The Topic 4 analysis showed that children on the east side of the interstate carry more of the traffic exposure than those a mile away, for reasons rooted in decisions made long before any of them were born. I cannot move the interstate. I can, however, know which of my asthma patients live next to it. In a southern California cohort of 208 children, lifetime doctor-diagnosed asthma was associated with closer residential distance to a freeway (odds ratio 1.89 per interquartile range) and with measured outdoor nitrogen dioxide (Gauderman et al., 2005). The answer to the new question changes what happens next in a concrete way: a child who lives near the truck route and whose asthma is poorly controlled prompts a conversation about a portable HEPA air cleaner for the bedroom. In a small double-blind crossover trial of 43 children exposed to traffic particles, HEPA filtration lowered indoor traffic particle levels, and children who started the trial with poorly controlled asthma improved their Asthma Control Questionnaire scores from 1.3 to 0.9 (James et al., 2020). The trial was short and small, so I present the cleaner as a reasonable addition to guideline treatment, never a substitute for it.
The Lower Referral Threshold
Until now, the clinic referred for genetic counseling mostly when a patient asked or when the family history was striking enough to be obvious. The US Preventive Services Task Force (2019) recommends that primary care clinicians use a brief familial risk assessment tool for women whose own history or family history includes breast, ovarian, tubal or peritoneal cancer, or whose ancestry is linked to BRCA1 or BRCA2 variants, and refer those who screen positive for counseling. The change is to act on the positive screen at the same visit rather than recording it and waiting. Topic 3 added the second trigger. When a relative already carries a known pathogenic variant, the question is no longer whether risk is elevated; it is whether the patient has been offered testing for that specific variant. A meta-analysis of 87 studies found that only 41 percent of relatives at risk completed cascade genetic testing, and that uptake of counseling was higher when the medical team contacted relatives directly (63 percent) than when patients were left to pass the news along (35 percent; Frey et al., 2022). A patient who tells me about a sister's MSH2 result is exactly the relative that figure describes, so the referral is placed before the visit ends.
The Clopidogrel Check
Topic 1 established that pharmacogenomic results already reach our charts from the regional cardiology practice, which orders panels before some procedures. Of the drug-gene pairs on those panels, CYP2C19 and clopidogrel carries the clearest action for primary care. Clopidogrel is a prodrug activated largely by CYP2C19, and the Clinical Pharmacogenetics Implementation Consortium recommends an alternative antiplatelet agent for poor and intermediate metabolizers when no contraindication exists, a recommendation its 2022 update extended beyond coronary indications to some neurovascular ones (Lee et al., 2022). Our clinic starts clopidogrel most often after a transient ischemic attack or for peripheral artery disease. The change is a documented search of the chart before the first prescription. It takes about a minute, and it is manual on purpose, for the reason given in the section on the held item.
An Owner for Results That Arrive Late
Topic 6 traced a 28-day gap in the time from abnormal mammogram to diagnosis, and the first link in that chain was a call-back that failed because phone numbers had changed. The same failure applies to anything we send out. A genetic panel takes weeks, and by the time it returns, the visit that ordered it is over and nobody is holding it. Across the 19 studies in one systematic review, between 6.8 and 62 percent of laboratory tests and between 1.0 and 35.7 percent of radiology results were not followed up in ambulatory settings, and the reviewers noted how few practices had defined who was responsible for notifying the patient (Callen et al., 2012). Our change is to answer that question in advance. The coordinator logs each send-out with a due date and a name, and the phone number is confirmed at checkout rather than assumed from the last registration.
Three Things That Stay as They Are
Interpretation of complex variants stays with the genetic counselor. Topic 1 defined my role as recognizing risk, ordering or referring, and making sure results reach the patient; it did not make me the person who decides what a variant of uncertain significance means. The genetics nursing scope and standards describe advanced practice nurses integrating genomic information into care within their preparation and referring when interpretation exceeds it (American Nurses Association & International Society of Nurses in Genetics, 2016). A variant of uncertain significance on a consumer report will be acknowledged, documented and referred, and I will tell the patient plainly that it should not change screening until a counselor reviews it.
The epigenetic findings from Topic 2 do not change prenatal or adult care in the clinic. The Dutch Hunger Winter work found persistent differences in IGF2 methylation roughly six decades after prenatal famine exposure (Heijmans et al., 2008), which is a striking group-level finding. It offers no individual test, no threshold and no intervention beyond the nutrition counseling I already provide in pregnancy. Changing practice on its basis would be claiming more than the study showed, which was the central argument of that paper.
Detection of emerging threats stays with the health department. The Topic 5 discussion concluded that detection fails mainly when public health capacity is cut between emergencies. My part in that system is the notifiable disease report I already file and the unusual cluster I already call in. The course strengthened my view of why that call matters, but it did not generate a new action inside the visit, and inventing one would add work without adding detection.
One Implication on Hold Until the Record Can Show It
The implication with the largest potential reach is automatic: every prescriber should be warned at the moment of ordering when a patient's stored genotype affects the drug being ordered, for every drug-gene pair with a guideline, not only clopidogrel. That cannot happen in our clinic yet. Outside pharmacogenomic results arrive as scanned PDF documents in the media section of the chart. They are not stored as discrete genotype or phenotype entries, so no rule can read them and no alert can fire. Hicks et al. (2016) describe why decision support is the necessary route for pharmacogenomics in practice: results last a lifetime, the number of actionable pairs keeps growing, and interpretation is too complex to leave to memory at the point of prescribing. All of those depend on results that the record can read.
The release condition is specific. When the health system's record accepts pharmacogenomic results as discrete phenotype entries, such as CYP2C19 poor metabolizer, and a rule is built to match those entries against orders, the manual clopidogrel search can be retired and the broader implication applied. I have raised the request with the regional informatics team and will not describe it as a change in our practice until the display exists. The manual check is a bridge for the single pair where the stakes are highest in our population.
What I Need to Do Personally
Three of the four changes need something from me beyond intention. The referral change needs the medical director to approve a standing workflow so that a positive screen generates the referral order during rooming rather than waiting for my review at the end of the day. The structured field for the interstate question and the send-out log both need a small build in the record, which I will request through the clinic manager with the exact field names written out so the request cannot be misread. The HEPA conversation needs a one-page family handout and an answer to the cost question, since the cleaners are not covered by most of our payers; I will check whether the county asthma program's supply fund can cover them for children on Medicaid. Personally, I need to be fluent in the brief familial risk tool the clinic adopts, and I need enough pharmacogenomic grounding to explain a CYP2C19 result to a patient without overstating it, which I will build through the continuing education the health system already offers its clinicians.
How I Will Know in Six Months
On September 1, 2027, I will pull four numbers from the record and compare them with the three months before the changes began. First, the share of asthma visits for children with the interstate field completed; below 80 percent means the question is not being asked. Second, the count of genetic counseling referrals generated by a positive screen or a relative's known variant; if that count has not risen from the current baseline of about two a month, the lower threshold exists only on paper. Third, the share of new clopidogrel prescriptions with a documented genotype search; anything short of every prescription means the check has become optional. Fourth, the share of send-out results closed with patient notification within 14 days of their return. If a measure falls short, I will look first at whether the owner named in Table 1 has the time and the tools, since a change that relies on goodwill alone will not last to the following year. The held item has its own check: whether the discrete display has been built. If it has not, it stays on hold, and I will say so at the next quality meeting rather than let it drift out of view.
References
American Nurses Association & International Society of Nurses in Genetics. (2016). Genetics/genomics nursing: Scope and standards of practice (2nd ed.).
Callen, J. L., Westbrook, J. I., Georgiou, A., & Li, J. (2012). Failure to follow-up test results for ambulatory patients: A systematic review. Journal of General Internal Medicine, 27(10), 1334-1348. https://doi.org/10.1007/s11606-011-1949-5
Frey, M. K., Ahsan, M. D., Bergeron, H., Lin, J., Li, X., Fowlkes, R. K., Narayan, P., Nitecki, R., Rauh-Hain, J. A., Moss, H. A., Baltich Nelson, B., Thomas, C., Christos, P. J., Hamilton, J. G., Chapman-Davis, E., Cantillo, E., Holcomb, K., Kurian, A. W., Lipkin, S., Offit, K., & Sharaf, R. N. (2022). Cascade testing for hereditary cancer syndromes: Should we move toward direct relative contact? A systematic review and meta-analysis. Journal of Clinical Oncology, 40(35), 4129-4143. https://doi.org/10.1200/JCO.22.00303
Gauderman, W. J., Avol, E., Lurmann, F., Kuenzli, N., Gilliland, F., Peters, J., & McConnell, R. (2005). Childhood asthma and exposure to traffic and nitrogen dioxide. Epidemiology, 16(6), 737-743. https://doi.org/10.1097/01.ede.0000181308.51440.75
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. E., & Lumey, L. H. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proceedings of the National Academy of Sciences, 105(44), 17046-17049. https://doi.org/10.1073/pnas.0806560105
Hicks, J. K., Dunnenberger, H. M., Gumpper, K. F., Haidar, C. E., & Hoffman, J. M. (2016). Integrating pharmacogenomics into electronic health records with clinical decision support. American Journal of Health-System Pharmacy, 73(23), 1967-1976. https://doi.org/10.2146/ajhp160030
James, C., Bernstein, D. I., Cox, J., Ryan, P., Wolfe, C., Jandarov, R., Newman, N., Indugula, R., & Reponen, T. (2020). HEPA filtration improves asthma control in children exposed to traffic-related airborne particles. Indoor Air, 30(2), 235-243. https://doi.org/10.1111/ina.12625
Lee, C. R., Luzum, J. A., Sangkuhl, K., Gammal, R. S., Sabatine, M. S., Stein, C. M., Kisor, D. F., Limdi, N. A., Lee, Y. M., Scott, S. A., Hulot, J. S., Roden, D. M., Gaedigk, A., Caudle, K. E., Klein, T. E., Johnson, J. A., & Shuldiner, A. R. (2022). Clinical Pharmacogenetics Implementation Consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update. Clinical Pharmacology & Therapeutics, 112(5), 959-967. https://doi.org/10.1002/cpt.2526
US Preventive Services Task Force. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement. JAMA, 322(7), 652-665. https://doi.org/10.1001/jama.2019.10987
What the DNP 810 Topic 8 instructions ask for
Topic 8 in DNP-810 asks students to synthesize what the course's emerging areas mean for their practice. Strong syntheses choose a level of change, such as a single visit, and state each implication as an action that can be scheduled, assigned or observed, with an owner. Students should trace each change to the topic that produced it, name what will not change and why, and identify implications that must wait for systems to support them. The synthesis should say what the student must do personally and how success will be checked at a stated date, rather than ending on general commitments to lifelong learning. A table of changes, sources and owners helps faculty see the synthesis at a glance, and the measures should be ones the student can actually pull from the record.
How the DNP-810 Topic 8 example is put together
The finished example sorts rather than summarizes. Four changes are stated at the level of an action: a question added to the intake, a referral threshold lowered, a drug choice checked against a result already in the record, and a follow up owner assigned for results that arrive after the visit. Three things explicitly do not change, including the interpretation of complex variants, which stays with a counselor. One implication is placed in a holding position, because it depends on results being visible in a record system that currently cannot display them, and the example names the change that would release it. Each item carries the course topic it came from, so the synthesis is traceable.
Where the marks sit in the DNP 810 Topic 8 rubric
Faculty reward implications stated as owned actions. An Excellent synthesis tables four changes with their source topics and owners, from an interstate field for pediatric asthma visits to a familial risk screen during rooming. Credit goes to a clopidogrel check for CYP2C19 results carried from Topic 1. The rubric values three constants, such as variant interpretation staying with the genetic counselor, and holding automatic genotype alerts until the record can show them. Top marks go to four numbers to pull on September 1, 2027, with thresholds such as 80 percent.
Common DNP 810 Topic 8 mistakes, and how to avoid them
The recurring problem in closing papers is a summary of the course rather than a synthesis of it, and the symptom is a paragraph per topic in the order they were taught. A second failure is claiming everything changes at the bedside, which is both untrue and impossible to act on. Marks also go for stating implications as awareness rather than as actions, since increased awareness cannot be scheduled, assigned or checked. Syntheses with nothing held back ignore the system constraints the course spent several topics establishing. Items with no traceable origin leave the reader unable to check the reasoning. Papers with no follow up point commit to nothing beyond the submission date.
Get a DNP-810 Topic 8 example written to your instructions
Send the DNP-810 Topic 8 instructions and the rubric your classroom posts, with any framework your section requires. We write a custom example to those criteria, sorting implications into what changes, what does not and what waits, with each item traced to its topic and a six month check attached, in 24 to 48 hours. The first is free.
More DNP 810 papers and DNP samples
- DNP 810 Topic 1: Genomic Practice Role Paper
- DNP 810 Topic 2: Gene Environment Interaction Paper
- DNP 810 Topic 3: Genetic Testing Disclosure Case
- DNP 810 Topic 4: Environmental Exposure Analysis
- DNP 810 Topic 5: Emerging Threat DQ Pair
- DNP 810 Topic 6: Social Conditions Analysis
- DNP 810 Topic 7: DNP-810 Topic 7 Science to Population Paper
- DNP 815A Topic 8: Theory Durability Statement
- DNP 805 Topic 8: Informatics Governance Analysis
- DNP 820 Topic 8: Dissemination Audience Plan
- DNP 801A Topic 8: Readiness Statement
DNP 810 Topic 8 questions, answered
Why name things that do not change?
Because a synthesis claiming universal change has not weighed its own evidence. Complex variant interpretation stays with a counselor. Most prescribing is unaffected by any genomic result currently in the record. Saying so makes the four things that do change more credible, and it shows the writer distinguishing between what the science suggests and what practice can absorb.
What makes an implication actionable?
It can be scheduled, assigned or observed. Adding a family history question to intake is actionable. Assigning an owner to results arriving after a visit is actionable. Developing greater genomic awareness is not, because nobody could tell in June whether it happened. Convert each conclusion into something a colleague could put on a list.
How should the paper end?
With a check. Naming what you would look at in six months to see whether the four changes happened, and what would count as them not happening, is the most useful closing move available. Most syntheses end on aspiration, which is why most of them are forgotten by the following course.
Where can I find a free DNP 810 Topic 8 sample paper?
The synthesis for DNP 810 Topic 8 covers the setting and level of change, four changes with owners, three things that stay, one implication on hold, what the writer must do personally and how success will be checked. Paste in your DNP 810 Topic 8 prompt and a free synthesis follows.
Why name things that do not change in DNP 810 Topic 8?
A synthesis claiming universal change reads as untested. Naming constants, such as leaving variant interpretation to the genetic counselor, shows the implications were weighed.